U.K. agency rejects Eli Lilly's Mounjaro for type 2 diabetes.
TL;DR Summary
The UK's National Institute for Health and Care Excellence (NICE) has declined to recommend Eli Lilly's Mounjaro, a new medication that helps patients lose weight, for people with type 2 diabetes without additional evidence. NICE has asked Lilly for more data to address the uncertainties in the clinical evidence when compared to all relevant alternative treatments.
Topics:health#eli-lilly#healthcare#mounjaro#national-institute-for-health-and-care-excellence#type-2-diabetes#uk
Reading Insights
Total Reads
0
Unique Readers
11
Time Saved
1 min
vs 1 min read
Condensed
72%
201 → 56 words
Want the full story? Read the original article
Read on STAT